表紙
市場調查報告書

全球血液篩檢市場

Blood Screening

出版商 Global Industry Analysts, Inc. 商品編碼 898150
出版日期 內容資訊 英文 382 Pages
商品交期: 最快1-2個工作天內
價格
全球血液篩檢市場 Blood Screening
出版日期: 2020年09月01日內容資訊: 英文 382 Pages
簡介

本報告提供全球血液篩檢市場相關調查,提供市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業簡介等相關資訊。

第1章 調查方法

第2章 摘要整理

  • 市場概要
    • 全球競爭市場佔有率
      • 全球市場佔有率方案
  • 各分類市場佔有率
    • 核酸檢驗
    • 酵素免疫吸附法(ELISA)
    • 迅速檢驗
    • 次世代定序
    • 試劑·套件
    • 計量儀器
    • 軟體·服務
  • 主要參與企業
  • 市場趨勢和促進因素
  • 全球市場預測

第3章 市場分析

  • 各地區市場分析
  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲各國
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞洲各國
  • 南美
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他的南美各國
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東各國
  • 非洲各國

第4章 競爭

  • ABBOTT LABORATORIES
  • BECKMAN COULTER
  • BIO-RAD LABORATORIES
  • F. HOFFMANN-LA ROCHE AG
  • GRIFOLS INTERNATIONAL SA
  • ORTHO CLINICAL DIAGNOSTICS
  • SIEMENS HEALTHINEERS
  • THERMO FISHER SCIENTIFIC
  • BIOMeRIEUX SA

第5章 相關調查

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP10749

Global Blood Screening Market to Reach $4 Billion by 2027

Amid the COVID-19 crisis, the global market for Blood Screening estimated at US$2.3 Billion in the year 2020, is projected to reach a revised size of US$4 Billion by 2027, growing at a CAGR of 8.4% over the analysis period 2020-2027. Nucleic Acid Test (NAT), one of the segments analyzed in the report, is projected to record a 8.4% CAGR and reach US$1.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Enzyme-Linked Immunosorbent Assay (ELISA) segment is readjusted to a revised 8.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $611.3 Million, While China is Forecast to Grow at 12.7% CAGR

The Blood Screening market in the U.S. is estimated at US$611.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$910.3 Million by the year 2027 trailing a CAGR of 12.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.6% and 7.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.5% CAGR.

Rapid Tests Segment to Record 9% CAGR

In the global Rapid Tests segment, USA, Canada, Japan, China and Europe will drive the 8.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$256 Million in the year 2020 will reach a projected size of US$449.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$554.3 Million by the year 2027, while Latin America will expand at a 10.6% CAGR through the analysis period. We bring years of research experience to this 9th edition of our report. The 382-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Becton, Dickinson & Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Grifols International SA
  • Ortho Clinical Diagnostics, Inc.
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Blood Screening Market to Witness Moderate Growth
    • The Nucleic Acid Test (NAT) Segment to Register Highest Growth
    • Global Competitor Market Shares
    • Blood Screening Competitor Market Share Scenario Worldwide (in %): 2019 &
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increase in Blood Donation Rates to Bode Well for Market Growth
    • Percentage of People Preferring to Donate Blood by Select Countries:
    • Various Initiatives to Donate Blood Propel Market Growth
    • Rising Incidence of Infectious Diseases
    • Total Number of Disease Cases Reported in the US due to Infected Fleas, Ticks, and Mosquitoes: 2004
    • Disease Response Towards Climate Change during the Recent Past
    • Opportunities and Challenges in Blood Screening
    • Innovations to Propel Market Growth
    • Various Measures for Ensuring Donated Blood Safety, a Key Driver for Market Growth
    • Introduction of Novel Products to Support Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: Blood Screening Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020
    • TABLE 2: Blood Screening Global Retrospective Market Scenario in US$ Million by Region/Country: 2012
    • TABLE 3: Blood Screening Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS
    • TABLE 4: Nucleic Acid Test (NAT) (Technology) World Market by Region/Country in US$ Million: 2020 to
    • TABLE 5: Nucleic Acid Test (NAT) (Technology) Historic Market Analysis by Region/Country in US$ Million: 2012 to
    • TABLE 6: Nucleic Acid Test (NAT) (Technology) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS
    • TABLE 7: Enzyme-Linked Immunosorbent Assay (ELISA) (Technology) Potential Growth Markets Worldwide in US$ Million: 2020 to
    • TABLE 8: Enzyme-Linked Immunosorbent Assay (ELISA) (Technology) Historic Market Perspective by Region/Country in US$ Million: 2012 to
    • TABLE 9: Enzyme-Linked Immunosorbent Assay (ELISA) (Technology) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS
    • TABLE 10: Rapid Tests (Technology) Geographic Market Spread Worldwide in US$ Million: 2020 to
    • TABLE 11: Rapid Tests (Technology) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to
    • TABLE 12: Rapid Tests (Technology) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS
    • TABLE 13: Western Blot Assay (Technology) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to
    • TABLE 14: Western Blot Assay (Technology) Market Historic Review by Region/Country in US$ Million: 2012 to
    • TABLE 15: Western Blot Assay (Technology) Market Share Breakdown by Region/Country: 2012 VS 2020 VS
    • TABLE 16: Next-Generation Sequencing (NGS) (Technology) World Market by Region/Country in US$ Million: 2020 to
    • TABLE 17: Next-Generation Sequencing (NGS) (Technology) Historic Market Analysis by Region/Country in US$ Million: 2012 to
    • TABLE 18: Next-Generation Sequencing (NGS) (Technology) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS
    • TABLE 19: Reagents & Kits (Product & Service) World Market Estimates and Forecasts in US$ Million by Region/Country: 2020 to
    • TABLE 20: Reagents & Kits (Product & Service) Market Worldwide Historic Review by Region/Country in US$ Million: 2012 to
    • TABLE 21: Reagents & Kits (Product & Service) Market Percentage Share Distribution by Region/Country: 2012 VS 2020 VS
    • TABLE 22: Instruments (Product & Service) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2020 to
    • TABLE 23: Instruments (Product & Service) Global Historic Demand in US$ Million by Region/Country: 2012 to
    • TABLE 24: Instruments (Product & Service) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS
    • TABLE 25: Software & Services (Product & Service) World Market by Region/Country in US$ Million: 2020 to
    • TABLE 26: Software & Services (Product & Service) Historic Market Analysis by Region/Country in US$ Million: 2012 to
    • TABLE 27: Software & Services (Product & Service) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS
    • TABLE 28: Blood Banks (End-Use) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2020
    • TABLE 29: Blood Banks (End-Use) Retrospective Demand Analysis in US$ Million by Region/Country: 2012
    • TABLE 30: Blood Banks (End-Use) Market Share Breakdown by Region/Country: 2012 VS 2020 VS
    • TABLE 31: Hospitals (End-Use) Demand Potential Worldwide in US$ Million by Region/Country: 2020
    • TABLE 32: Hospitals (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2012
    • TABLE 33: Hospitals (End-Use) Share Breakdown Review by Region/Country: 2012 VS 2020 VS

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Blood Screening Market Share (in %) by Company: 2019 &
    • Market Analytics
    • TABLE 34: Blood Screening Market in US$ Million in the United States by Technology: 2020
    • TABLE 35: United States Blood Screening Market Retrospective Analysis in US$ Million by Technology: 2012
    • TABLE 36: United States Blood Screening Market Share Breakdown by Technology: 2012 VS 2020 VS
    • TABLE 37: United States Blood Screening Market Estimates and Projections in US$ Million by Product & Service: 2020 to
    • TABLE 38: Blood Screening Market in the United States by Product & Service: A Historic Review in US$ Million for 2012
    • TABLE 39: United States Blood Screening Market Share Breakdown by Product & Service: 2012 VS 2020 VS
    • TABLE 40: United States Blood Screening Latent Demand Forecasts in US$ Million by End-Use: 2020 to
    • TABLE 41: Blood Screening Historic Demand Patterns in the United States by End-Use in US$ Million for 2012
    • TABLE 42: Blood Screening Market Share Breakdown in the United States by End-Use: 2012 VS 2020 VS
  • CANADA
    • TABLE 43: Blood Screening Market Analysis in Canada in US$ Million by Technology: 2020
    • TABLE 44: Blood Screening Market in Canada: Historic Review in US$ Million by Technology for the Period 2012
    • TABLE 45: Canadian Blood Screening Market Share Breakdown by Technology: 2012 VS 2020 VS
    • TABLE 46: Canadian Blood Screening Market Estimates and Forecasts in US$ Million by Product & Service: 2020 to
    • TABLE 47: Canadian Blood Screening Historic Market Review by Product & Service in US$ Million: 2012
    • TABLE 48: Blood Screening Market in Canada: Percentage Share Breakdown of Sales by Product & Service for 2012, 2020, and
    • TABLE 49: Canadian Blood Screening Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to
    • TABLE 50: Blood Screening Market in Canada: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012
    • TABLE 51: Canadian Blood Screening Market Share Analysis by End-Use: 2012 VS 2020 VS
  • JAPAN
    • TABLE 52: Japanese Medium & Long-Term Outlook for Blood Screening Market in US$ Million by Technology: 2020
    • TABLE 53: Blood Screening Market in Japan in US$ Million by Technology: 2012
    • TABLE 54: Japanese Blood Screening Market Percentage Share Distribution by Technology: 2012 VS 2020 VS
    • TABLE 55: Japanese Market for Blood Screening: Annual Sales Estimates and Projections in US$ Million by Product & Service for the Period 2020
    • TABLE 56: Blood Screening Market in Japan: Historic Sales Analysis in US$ Million by Product & Service for the Period 2012
    • TABLE 57: Japanese Blood Screening Market Share Analysis by Product & Service: 2012 VS 2020 VS
    • TABLE 58: Japanese Demand Estimates and Forecasts for Blood Screening in US$ Million by End-Use: 2020 to
    • TABLE 59: Japanese Blood Screening Market in US$ Million by End-Use: 2012
    • TABLE 60: Blood Screening Market Share Shift in Japan by End-Use: 2012 VS 2020 VS
  • CHINA
    • TABLE 61: Blood Screening Market Estimates and Forecasts in China in US$ Million by Technology: 2020
    • TABLE 62: Chinese Blood Screening Retrospective Market Scenario in US$ Million by Technology: 2012
    • TABLE 63: Blood Screening Market in China: Percentage Share Analysis by Technology for 2012, 2020, and
    • TABLE 64: Chinese Blood Screening Market Growth Prospects in US$ Million by Product & Service for the Period 2020
    • TABLE 65: Blood Screening Historic Market Analysis in China in US$ Million by Product & Service: 2012
    • TABLE 66: Chinese Blood Screening Market by Product & Service: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 67: Chinese Demand for Blood Screening in US$ Million by End-Use: 2020 to
    • TABLE 68: Blood Screening Market Review in China in US$ Million by End-Use: 2012
    • TABLE 69: Chinese Blood Screening Market Share Breakdown by End-Use: 2012 VS 2020 VS
  • EUROPE
    • Market Facts & Figures
    • European Blood Screening Market: Competitor Market Share Scenario (in %) for 2019 &
    • Market Analytics
    • TABLE 70: European Blood Screening Market Demand Scenario in US$ Million by Region/Country: 2020
    • TABLE 71: Blood Screening Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012
    • TABLE 72: European Blood Screening Market Share Shift by Region/Country: 2012 VS 2020 VS
    • TABLE 73: European Blood Screening Market Assessment in US$ Million by Technology: 2020
    • TABLE 74: European Blood Screening Historic Market Review in US$ Million by Technology: 2012
    • TABLE 75: Blood Screening Market in Europe: Percentage Breakdown of Sales by Technology for 2012, 2020, and
    • TABLE 76: European Blood Screening Market Estimates and Forecasts in US$ Million by Product & Service: 2020
    • TABLE 77: Blood Screening Market in Europe in US$ Million by Product & Service: A Historic Review for the Period 2012
    • TABLE 78: European Blood Screening Market Share Breakdown by Product & Service: 2012 VS 2020 VS
    • TABLE 79: European Blood Screening Addressable Market Opportunity in US$ Million by End-Use: 2020
    • TABLE 80: Blood Screening Market in Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012
    • TABLE 81: European Blood Screening Market Share Analysis by End-Use: 2012 VS 2020 VS
  • FRANCE
    • TABLE 82: French Blood Screening Market Estimates and Projections in US$ Million by Technology: 2020
    • TABLE 83: French Blood Screening Historic Market Analysis in US$ Million by Technology: 2012
    • TABLE 84: French Blood Screening Market Share Breakdown by Technology: 2012 VS 2020 VS
    • TABLE 85: Blood Screening Market in France by Product & Service: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 86: French Blood Screening Historic Market Scenario in US$ Million by Product & Service: 2012
    • TABLE 87: French Blood Screening Market Share Analysis by Product & Service: 2012 VS 2020 VS
    • TABLE 88: Blood Screening Quantitative Demand Analysis in France in US$ Million by End-Use: 2020
    • TABLE 89: French Blood Screening Historic Market Review in US$ Million by End-Use: 2012
    • TABLE 90: French Blood Screening Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and
  • GERMANY
    • TABLE 91: German Blood Screening Latent Demand Forecasts in US$ Million by Technology: 2020
    • TABLE 92: Blood Screening Market in Germany: A Historic Perspective by Technology in US$ Million for the Period 2012
    • TABLE 93: German Blood Screening Market Share Breakdown by Technology: 2012 VS 2020 VS
    • TABLE 94: Blood Screening Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product & Service for the Period 2020
    • TABLE 95: German Blood Screening Historic Market Analysis in US$ Million by Product & Service: 2012
    • TABLE 96: German Blood Screening Market Share Breakdown by Product & Service: 2012 VS 2020 VS
    • TABLE 97: Blood Screening Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020
    • TABLE 98: German Blood Screening Market in Retrospect in US$ Million by End-Use: 2012
    • TABLE 99: Blood Screening Market Share Distribution in Germany by End-Use: 2012 VS 2020 VS
  • ITALY
    • TABLE 100: Blood Screening Market Estimates and Forecasts in Italy in US$ Million by Technology: 2020
    • TABLE 101: Italian Blood Screening Retrospective Market Scenario in US$ Million by Technology: 2012
    • TABLE 102: Blood Screening Market in Italy: Percentage Share Analysis by Technology for 2012, 2020, and
    • TABLE 103: Italian Blood Screening Market Growth Prospects in US$ Million by Product & Service for the Period 2020
    • TABLE 104: Blood Screening Historic Market Analysis in Italy in US$ Million by Product & Service: 2012
    • TABLE 105: Italian Blood Screening Market by Product & Service: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 106: Italian Demand for Blood Screening in US$ Million by End-Use: 2020 to
    • TABLE 107: Blood Screening Market Review in Italy in US$ Million by End-Use: 2012
    • TABLE 108: Italian Blood Screening Market Share Breakdown by End-Use: 2012 VS 2020 VS
  • UNITED KINGDOM
    • TABLE 109: United Kingdom Medium & Long-Term Outlook for Blood Screening Market in US$ Million by Technology: 2020
    • TABLE 110: Blood Screening Market in the United Kingdom in US$ Million by Technology: 2012
    • TABLE 111: United Kingdom Blood Screening Market Percentage Share Distribution by Technology: 2012 VS 2020 VS
    • TABLE 112: United Kingdom Market for Blood Screening: Annual Sales Estimates and Projections in US$ Million by Product & Service for the Period 2020
    • TABLE 113: Blood Screening Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product & Service for the Period 2012
    • TABLE 114: United Kingdom Blood Screening Market Share Analysis by Product & Service: 2012 VS 2020 VS
    • TABLE 115: United Kingdom Demand Estimates and Forecasts for Blood Screening in US$ Million by End-Use: 2020 to
    • TABLE 116: United Kingdom Blood Screening Market in US$ Million by End-Use: 2012
    • TABLE 117: Blood Screening Market Share Shift in the United Kingdom by End-Use: 2012 VS 2020 VS
  • SPAIN
    • TABLE 118: Blood Screening Market Analysis in Spain in US$ Million by Technology: 2020
    • TABLE 119: Blood Screening Market in Spain: Historic Review in US$ Million by Technology for the Period 2012
    • TABLE 120: Spanish Blood Screening Market Share Breakdown by Technology: 2012 VS 2020 VS
    • TABLE 121: Spanish Blood Screening Market Estimates and Forecasts in US$ Million by Product & Service: 2020 to
    • TABLE 122: Spanish Blood Screening Historic Market Review by Product & Service in US$ Million: 2012
    • TABLE 123: Blood Screening Market in Spain: Percentage Share Breakdown of Sales by Product & Service for 2012, 2020, and
    • TABLE 124: Spanish Blood Screening Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to
    • TABLE 125: Blood Screening Market in Spain: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012
    • TABLE 126: Spanish Blood Screening Market Share Analysis by End-Use: 2012 VS 2020 VS
  • RUSSIA
    • TABLE 127: Blood Screening Market in US$ Million in Russia by Technology: 2020
    • TABLE 128: Russian Blood Screening Market Retrospective Analysis in US$ Million by Technology: 2012
    • TABLE 129: Russian Blood Screening Market Share Breakdown by Technology: 2012 VS 2020 VS
    • TABLE 130: Russian Blood Screening Market Estimates and Projections in US$ Million by Product & Service: 2020 to
    • TABLE 131: Blood Screening Market in Russia by Product & Service: A Historic Review in US$ Million for 2012
    • TABLE 132: Russian Blood Screening Market Share Breakdown by Product & Service: 2012 VS 2020 VS
    • TABLE 133: Russian Blood Screening Latent Demand Forecasts in US$ Million by End-Use: 2020 to
    • TABLE 134: Blood Screening Historic Demand Patterns in Russia by End-Use in US$ Million for 2012
    • TABLE 135: Blood Screening Market Share Breakdown in Russia by End-Use: 2012 VS 2020 VS
  • REST OF EUROPE
    • TABLE 136: Rest of Europe Blood Screening Market Assessment in US$ Million by Technology: 2020
    • TABLE 137: Rest of Europe Blood Screening Historic Market Review in US$ Million by Technology: 2012
    • TABLE 138: Blood Screening Market in Rest of Europe: Percentage Breakdown of Sales by Technology for 2012, 2020, and
    • TABLE 139: Rest of Europe Blood Screening Market Estimates and Forecasts in US$ Million by Product & Service: 2020
    • TABLE 140: Blood Screening Market in Rest of Europe in US$ Million by Product & Service: A Historic Review for the Period 2012
    • TABLE 141: Rest of Europe Blood Screening Market Share Breakdown by Product & Service: 2012 VS 2020 VS
    • TABLE 142: Rest of Europe Blood Screening Addressable Market Opportunity in US$ Million by End-Use: 2020
    • TABLE 143: Blood Screening Market in Rest of Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012
    • TABLE 144: Rest of Europe Blood Screening Market Share Analysis by End-Use: 2012 VS 2020 VS
  • ASIA-PACIFIC
    • TABLE 145: Asia-Pacific Blood Screening Market Estimates and Forecasts in US$ Million by Region/Country: 2020
    • TABLE 146: Blood Screening Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2012
    • TABLE 147: Asia-Pacific Blood Screening Market Share Analysis by Region/Country: 2012 VS 2020 VS
    • TABLE 148: Asia-Pacific Blood Screening Market Estimates and Projections in US$ Million by Technology: 2020
    • TABLE 149: Asia-Pacific Blood Screening Historic Market Analysis in US$ Million by Technology: 2012
    • TABLE 150: Asia-Pacific Blood Screening Historic Market Analysis in US$ Million by Technology: 2012 VS 2020 VS
    • TABLE 151: Blood Screening Market in Asia-Pacific by Product & Service: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 152: Asia-Pacific Blood Screening Historic Market Scenario in US$ Million by Product & Service: 2012
    • TABLE 153: Asia-Pacific Blood Screening Market Share Analysis by Product & Service: 2012 VS 2020 VS
    • TABLE 154: Blood Screening Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2020
    • TABLE 155: Asia-Pacific Blood Screening Historic Market Review in US$ Million by End-Use: 2012
    • TABLE 156: Asia-Pacific Blood Screening Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and
  • AUSTRALIA
    • TABLE 157: Australian Blood Screening Latent Demand Forecasts in US$ Million by Technology: 2020
    • TABLE 158: Blood Screening Market in Australia: A Historic Perspective by Technology in US$ Million for the Period 2012
    • TABLE 159: Australian Blood Screening Market Share Breakdown by Technology: 2012 VS 2020 VS
    • TABLE 160: Blood Screening Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Product & Service for the Period 2020
    • TABLE 161: Australian Blood Screening Historic Market Analysis in US$ Million by Product & Service: 2012
    • TABLE 162: Australian Blood Screening Market Share Breakdown by Product & Service: 2012 VS 2020 VS
    • TABLE 163: Blood Screening Market in Australia: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020
    • TABLE 164: Australian Blood Screening Market in Retrospect in US$ Million by End-Use: 2012
    • TABLE 165: Blood Screening Market Share Distribution in Australia by End-Use: 2012 VS 2020 VS
  • INDIA
    • TABLE 166: Blood Screening Market Analysis in India in US$ Million by Technology: 2020
    • TABLE 167: Blood Screening Market in India: Historic Review in US$ Million by Technology for the Period 2012
    • TABLE 168: Indian Blood Screening Market Share Breakdown by Technology: 2012 VS 2020 VS
    • TABLE 169: Indian Blood Screening Market Estimates and Forecasts in US$ Million by Product & Service: 2020 to
    • TABLE 170: Indian Blood Screening Historic Market Review by Product & Service in US$ Million: 2012
    • TABLE 171: Blood Screening Market in India: Percentage Share Breakdown of Sales by Product & Service for 2012, 2020, and
    • TABLE 172: Indian Blood Screening Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to
    • TABLE 173: Blood Screening Market in India: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012
    • TABLE 174: Indian Blood Screening Market Share Analysis by End-Use: 2012 VS 2020 VS
  • SOUTH KOREA
    • TABLE 175: Blood Screening Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Technology for the Period 2020
    • TABLE 176: South Korean Blood Screening Historic Market Analysis in US$ Million by Technology: 2012
    • TABLE 177: Blood Screening Market Share Distribution in South Korea by Technology: 2012 VS 2020 VS
    • TABLE 178: Blood Screening Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Product & Service for the Period 2020
    • TABLE 179: South Korean Blood Screening Historic Market Analysis in US$ Million by Product & Service: 2012
    • TABLE 180: Blood Screening Market Share Distribution in South Korea by Product & Service: 2012 VS 2020 VS
    • TABLE 181: Blood Screening Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by End-Use for the Period 2020
    • TABLE 182: South Korean Blood Screening Historic Market Analysis in US$ Million by End-Use: 2012
    • TABLE 183: Blood Screening Market Share Distribution in South Korea by End-Use: 2012 VS 2020 VS
  • REST OF ASIA-PACIFIC
    • TABLE 184: Rest of Asia-Pacific Medium & Long-Term Outlook for Blood Screening Market in US$ Million by Technology: 2020
    • TABLE 185: Blood Screening Market in Rest of Asia-Pacific in US$ Million by Technology: 2012
    • TABLE 186: Rest of Asia-Pacific Blood Screening Market Percentage Share Distribution by Technology: 2012 VS 2020 VS
    • TABLE 187: Rest of Asia-Pacific Market for Blood Screening: Annual Sales Estimates and Projections in US$ Million by Product & Service for the Period 2020
    • TABLE 188: Blood Screening Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Product & Service for the Period 2012
    • TABLE 189: Rest of Asia-Pacific Blood Screening Market Share Analysis by Product & Service: 2012 VS 2020 VS
    • TABLE 190: Rest of Asia-Pacific Demand Estimates and Forecasts for Blood Screening in US$ Million by End-Use: 2020 to
    • TABLE 191: Rest of Asia-Pacific Blood Screening Market in US$ Million by End-Use: 2012
    • TABLE 192: Blood Screening Market Share Shift in Rest of Asia-Pacific by End-Use: 2012 VS 2020 VS
  • LATIN AMERICA
    • TABLE 193: Latin American Blood Screening Market Trends by Region/Country in US$ Million: 2020
    • TABLE 194: Blood Screening Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2012
    • TABLE 195: Latin American Blood Screening Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and
    • TABLE 196: Blood Screening Market Estimates and Forecasts in Latin America in US$ Million by Technology: 2020
    • TABLE 197: Latin American Blood Screening Retrospective Market Scenario in US$ Million by Technology: 2012
    • TABLE 198: Blood Screening Market in Latin America : Percentage Analysis by Technology for 2012, 2020, and
    • TABLE 199: Latin American Blood Screening Market Growth Prospects in US$ Million by Product & Service for the Period 2020
    • TABLE 200: Blood Screening Historic Market Analysis in Latin America in US$ Million by Product & Service: 2012
    • TABLE 201: Latin American Blood Screening Market by Product & Service: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 202: Latin American Demand for Blood Screening in US$ Million by End-Use: 2020 to
    • TABLE 203: Blood Screening Market Review in Latin America in US$ Million by End-Use: 2012
    • TABLE 204: Latin American Blood Screening Market Share Breakdown by End-Use: 2012 VS 2020 VS
  • ARGENTINA
    • TABLE 205: Argentinean Blood Screening Market Assessment in US$ Million by Technology: 2020
    • TABLE 206: Argentinean Blood Screening Historic Market Review in US$ Million by Technology: 2012
    • TABLE 207: Blood Screening Market in Argentina: Percentage Breakdown of Sales by Technology for 2012, 2020, and
    • TABLE 208: Argentinean Blood Screening Market Estimates and Forecasts in US$ Million by Product & Service: 2020
    • TABLE 209: Blood Screening Market in Argentina in US$ Million by Product & Service: A Historic Review for the Period 2012
    • TABLE 210: Argentinean Blood Screening Market Share Breakdown by Product & Service: 2012 VS 2020 VS
    • TABLE 211: Argentinean Blood Screening Addressable Market Opportunity in US$ Million by End-Use: 2020
    • TABLE 212: Blood Screening Market in Argentina: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012
    • TABLE 213: Argentinean Blood Screening Market Share Analysis by End-Use: 2012 VS 2020 VS
  • BRAZIL
    • TABLE 214: Brazilian Blood Screening Market Estimates and Projections in US$ Million by Technology: 2020
    • TABLE 215: Brazilian Blood Screening Historic Market Analysis in US$ Million by Technology: 2012
    • TABLE 216: Brazilian Blood Screening Market Share Breakdown by Technology: 2012 VS 2020 VS
    • TABLE 217: Blood Screening Market in Brazil by Product & Service: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 218: Brazilian Blood Screening Historic Market Scenario in US$ Million by Product & Service: 2012
    • TABLE 219: Brazilian Blood Screening Market Share Analysis by Product & Service: 2012 VS 2020 VS
    • TABLE 220: Blood Screening Quantitative Demand Analysis in Brazil in US$ Million by End-Use: 2020
    • TABLE 221: Brazilian Blood Screening Historic Market Review in US$ Million by End-Use: 2012
    • TABLE 222: Brazilian Blood Screening Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and
  • MEXICO
    • TABLE 223: Mexican Blood Screening Latent Demand Forecasts in US$ Million by Technology: 2020
    • TABLE 224: Blood Screening Market in Mexico: A Historic Perspective by Technology in US$ Million for the Period 2012
    • TABLE 225: Mexican Blood Screening Market Share Breakdown by Technology: 2012 VS 2020 VS
    • TABLE 226: Blood Screening Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Product & Service for the Period 2020
    • TABLE 227: Mexican Blood Screening Historic Market Analysis in US$ Million by Product & Service: 2012
    • TABLE 228: Mexican Blood Screening Market Share Breakdown by Product & Service: 2012 VS 2020 VS
    • TABLE 229: Blood Screening Market in Mexico: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020
    • TABLE 230: Mexican Blood Screening Market in Retrospect in US$ Million by End-Use: 2012
    • TABLE 231: Blood Screening Market Share Distribution in Mexico by End-Use: 2012 VS 2020 VS
  • REST OF LATIN AMERICA
    • TABLE 232: Blood Screening Market in US$ Million in Rest of Latin America by Technology: 2020
    • TABLE 233: Rest of Latin America Blood Screening Market Retrospective Analysis in US$ Million by Technology: 2012
    • TABLE 234: Rest of Latin America Blood Screening Market Share Breakdown by Technology: 2012 VS 2020 VS
    • TABLE 235: Rest of Latin America Blood Screening Market Estimates and Projections in US$ Million by Product & Service: 2020 to
    • TABLE 236: Blood Screening Market in Rest of Latin America by Product & Service: A Historic Review in US$ Million for 2012
    • TABLE 237: Rest of Latin America Blood Screening Market Share Breakdown by Product & Service: 2012 VS 2020 VS
    • TABLE 238: Rest of Latin America Blood Screening Latent Demand Forecasts in US$ Million by End-Use: 2020 to
    • TABLE 239: Blood Screening Historic Demand Patterns in Rest of Latin America by End-Use in US$ Million for 2012
    • TABLE 240: Blood Screening Market Share Breakdown in Rest of Latin America by End-Use: 2012 VS 2020 VS
  • MIDDLE EAST
    • TABLE 241: The Middle East Blood Screening Market Estimates and Forecasts in US$ Million by Region/Country: 2020
    • TABLE 242: Blood Screening Market in the Middle East by Region/Country in US$ Million: 2012
    • TABLE 243: The Middle East Blood Screening Market Share Breakdown by Region/Country: 2012, 2020, and
    • TABLE 244: The Middle East Blood Screening Market Analysis in US$ Million by Technology: 2020
    • TABLE 245: Blood Screening Market in the Middle East: Historic Review in US$ Million by Technology for the Period 2012
    • TABLE 246: The Middle East Blood Screening Market Share Breakdown by Technology: 2012 VS 2020 VS
    • TABLE 247: The Middle East Blood Screening Market Estimates and Forecasts in US$ Million by Product & Service: 2020 to
    • TABLE 248: The Middle East Blood Screening Historic Market by Product & Service in US$ Million: 2012
    • TABLE 249: Blood Screening Market in the Middle East: Percentage Share Breakdown of Sales by Product & Service for 2012,2020, and
    • TABLE 250: The Middle East Blood Screening Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to
    • TABLE 251: Blood Screening Market in the Middle East: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012
    • TABLE 252: The Middle East Blood Screening Market Share Analysis by End-Use: 2012 VS 2020 VS
  • IRAN
    • TABLE 253: Iranian Medium & Long-Term Outlook for Blood Screening Market in US$ Million by Technology: 2020
    • TABLE 254: Blood Screening Market in Iran in US$ Million by Technology: 2012
    • TABLE 255: Iranian Blood Screening Market Percentage Share Distribution by Technology: 2012 VS 2020 VS
    • TABLE 256: Iranian Market for Blood Screening: Annual Sales Estimates and Projections in US$ Million by Product & Service for the Period 2020
    • TABLE 257: Blood Screening Market in Iran: Historic Sales Analysis in US$ Million by Product & Service for the Period 2012
    • TABLE 258: Iranian Blood Screening Market Share Analysis by Product & Service: 2012 VS 2020 VS
    • TABLE 259: Iranian Demand Estimates and Forecasts for Blood Screening in US$ Million by End-Use: 2020 to
    • TABLE 260: Iranian Blood Screening Market in US$ Million by End-Use: 2012
    • TABLE 261: Blood Screening Market Share Shift in Iran by End-Use: 2012 VS 2020 VS
  • ISRAEL
    • TABLE 262: Israeli Blood Screening Market Assessment in US$ Million by Technology: 2020
    • TABLE 263: Israeli Blood Screening Historic Market Review in US$ Million by Technology: 2012
    • TABLE 264: Blood Screening Market in Israel: Percentage Breakdown of Sales by Technology for 2012, 2020, and
    • TABLE 265: Israeli Blood Screening Market Estimates and Forecasts in US$ Million by Product & Service: 2020
    • TABLE 266: Blood Screening Market in Israel in US$ Million by Product & Service: A Historic Review for the Period 2012
    • TABLE 267: Israeli Blood Screening Market Share Breakdown by Product & Service: 2012 VS 2020 VS
    • TABLE 268: Israeli Blood Screening Addressable Market Opportunity in US$ Million by End-Use: 2020
    • TABLE 269: Blood Screening Market in Israel: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012
    • TABLE 270: Israeli Blood Screening Market Share Analysis by End-Use: 2012 VS 2020 VS
  • SAUDI ARABIA
    • TABLE 271: Blood Screening Market Estimates and Forecasts in Saudi Arabia in US$ Million by Technology: 2020
    • TABLE 272: Saudi Arabian Blood Screening Retrospective Market Scenario in US$ Million by Technology: 2012
    • TABLE 273: Blood Screening Market in Saudi Arabia: Percentage Share Analysis by Technology for 2012, 2020, and
    • TABLE 274: Saudi Arabian Blood Screening Market Growth Prospects in US$ Million by Product & Service for the Period 2020
    • TABLE 275: Blood Screening Historic Market Analysis in Saudi Arabia in US$ Million by Product & Service: 2012
    • TABLE 276: Saudi Arabian Blood Screening Market by Product & Service: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 277: Saudi Arabian Demand for Blood Screening in US$ Million by End-Use: 2020 to
    • TABLE 278: Blood Screening Market Review in Saudi Arabia in US$ Million by End-Use: 2012
    • TABLE 279: Saudi Arabian Blood Screening Market Share Breakdown by End-Use: 2012 VS 2020 VS
  • UNITED ARAB EMIRATES
    • TABLE 280: Blood Screening Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Technology for the Period 2020
    • TABLE 281: United Arab Emirates Blood Screening Historic Market Analysis in US$ Million by Technology: 2012
    • TABLE 282: Blood Screening Market Share Distribution in United Arab Emirates by Technology: 2012 VS 2020 VS
    • TABLE 283: Blood Screening Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Product & Service for the Period 2020
    • TABLE 284: United Arab Emirates Blood Screening Historic Market Analysis in US$ Million by Product & Service: 2012
    • TABLE 285: Blood Screening Market Share Distribution in United Arab Emirates by Product & Service: 2012 VS 2020 VS
    • TABLE 286: Blood Screening Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by End-Use for the Period 2020
    • TABLE 287: United Arab Emirates Blood Screening Historic Market Analysis in US$ Million by End-Use: 2012
    • TABLE 288: Blood Screening Market Share Distribution in United Arab Emirates by End-Use: 2012 VS 2020 VS
  • REST OF MIDDLE EAST
    • TABLE 289: Rest of Middle East Blood Screening Latent Demand Forecasts in US$ Million by Technology: 2020
    • TABLE 290: Blood Screening Market in Rest of Middle East: A Historic Perspective by Technology in US$ Million for the Period 2012
    • TABLE 291: Rest of Middle East Blood Screening Market Share Breakdown by Technology: 2012 VS 2020 VS
    • TABLE 292: Blood Screening Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Product & Service for the Period 2020
    • TABLE 293: Rest of Middle East Blood Screening Historic Market Analysis in US$ Million by Product & Service: 2012
    • TABLE 294: Rest of Middle East Blood Screening Market Share Breakdown by Product & Service: 2012 VS 2020 VS
    • TABLE 295: Blood Screening Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020
    • TABLE 296: Rest of Middle East Blood Screening Market in Retrospect in US$ Million by End-Use: 2012
    • TABLE 297: Blood Screening Market Share Distribution in Rest of Middle East by End-Use: 2012 VS 2020 VS
  • AFRICA
    • TABLE 298: Blood Screening Market in US$ Million in Africa by Technology: 2020
    • TABLE 299: African Blood Screening Market Retrospective Analysis in US$ Million by Technology: 2012
    • TABLE 300: African Blood Screening Market Share Breakdown by Technology: 2012 VS 2020 VS
    • TABLE 301: African Blood Screening Market Estimates and Projections in US$ Million by Product & Service: 2020 to
    • TABLE 302: Blood Screening Market in Africa by Product & Service: A Historic Review in US$ Million for 2012
    • TABLE 303: African Blood Screening Market Share Breakdown by Product & Service: 2012 VS 2020 VS
    • TABLE 304: African Blood Screening Latent Demand Forecasts in US$ Million by End-Use: 2020 to
    • TABLE 305: Blood Screening Historic Demand Patterns in Africa by End-Use in US$ Million for 2012
    • TABLE 306: Blood Screening Market Share Breakdown in Africa by End-Use: 2012 VS 2020 VS

IV. COMPETITION

  • Total Companies Profiled: 46